Is Jazz Pharmaceuticals (JAZZ) Offering Value After Recent Pullback And 32.7% One Year Gain [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
The stock is down 6.9% over the last week and 3.8% over the last month, yet it is up 32.7% over the past year. This mix of short-term weakness and longer-term strength may change how you think about its risk and return profile. Recent coverage has focused on Jazz Pharmaceuticals as a specialty pharma name in focus, with attention on how its current product portfolio and pipeline position the business within the broader pharmaceuticals and biotech sector. That context helps frame why the shares have pulled back in the short term while still sitting on a stronger 1 year return of 32.7%. On our valuation checks, Jazz Pharmaceuticals currently scores 6 out of 6 . Next we will look at what that means across different valuation methods, before finishing with a simple way to keep all this valuation work in perspective. Jazz Pharmaceuticals delivered 32.7% returns over the last year. See how this stacks up to the rest of the Pharmaceuticals industry. A Discounted Cash Flow model take
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Truist Financial Corporation from $220.00 to $230.00. They now have a "buy" rating on the stock.MarketBeat
- Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Needham & Company LLC from $210.00 to $235.00. They now have a "buy" rating on the stock.MarketBeat
- Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals: A Strong Buy Due To Execution In Oncology [Seeking Alpha]Seeking Alpha
- Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer [Yahoo! Finance]Yahoo! Finance
JAZZ
Earnings
- 11/5/25 - Beat
JAZZ
Sec Filings
- 1/12/26 - Form 8-K
- 1/8/26 - Form 4
- 12/11/25 - Form 4
- JAZZ's page on the SEC website